We studied the effects of crude mouse lymphokines and cloned mouse inteferon-y on the interaction of Rickeffsia prowazekii with mouse macrophage-like RAW264.7 cells. Treatment of RAW264.7 cells with lymphokines before infection, after infection, or both before and after infection with R. prowazekii led to killing of a substantial proportion of the RAW264.7 cells. Such cytotoxicity required both lymphokines and viable R. prowazekii and did not occur in mouse fibroblastic L929 cells. Untreated cultures of RAW264.7 cells supported good growth of the Breini strain of R. prowazekii, but in lymphokine-treated cultures, little or no rickettsial growth occurred in the cells that survived the cytotoxic reaction. In addition, treatment of RAW264.7 cells with lymphokines before rickettsial infection was associated with suppression of the initial infection. The effects of cloned mouse interferon--y were similar to the effects of crude mouse lymphokines. Assessment of cytotoxicity, inhibition of the initial infection, and inhibition of rickettsial growth in RAW264.7 cells pretreated with various concentrations of interferon-y indicated that the effects of the lymphokines could be explained by the interferon--y that was present in these preparations. Treatment of RAW264.7 cells with interferon-y makes them unsuitable host cells for R. prowazekii.
antiserum is cleared from these macrophage-like cells (21) . These data suggest that RAW264.7 cells constitute a good model system for the study of R. prowazekii-macrophage interactions. RAW264.7 cells are easily cultured and readily lend themselves to experiments that might be difficult or impossible to perform with human monocyte-derived macrophages.
The survival and growth of R. prowazekii within nonprofessional phagocytes (mouse fibroblasts) are inhibited when the fibroblasts are treated with lymphokines produced by antigen-or concanavalin A-stimulated mouse spleen cells (24) . In addition, the growth of R. prowazekii within human fibroblasts is inhibited when the fibroblasts are treated with lymphokines produced by concanavalin A-stimulated human peripheral blood mononuclear cells (24) . Supernatant fluids obtained from cultures of antigen-or phytohemagglutininstimulated human leukocytes inhibit the growth of R. prowazekii not only in human fibroblasts but also in human endothelial cells and macrophages (30) . Studies with Rickettsia tsutsugamushi have shown that treatment of resident * Corresponding author. 303 mouse peritoneal macrophage cultures with supernatant fluids collected from antigen-stimulated cultures of mouse spleen cells markedly suppresses the ability of the macrophages to be infected with this rickettsia (13, 14) . In addition, untreated mouse macrophages support the growth of R.
tsutsugamushi, whereas lymphokine-treated macrophages have rickettsicidal activity (13) .
Most, if not all, of the antirickettsial activity that is observed in mouse lymphokine-treated mouse fibroblasts that are infected with R. prowazekii can be explained by the interferon--y (IFN--y) that is present in the lymphokine preparations (22) (23) (24) . Furthermore, mouse IFN-y has antirickettsial activity: cloned mouse IFN--y produced by Chinese hamster ovary cells and cloned mouse IFN--y produced by Escherichia coli inhibit the growth of R. prowazekii within mouse fibroblasts (22) .
The present study examines the effects of crude mouse lymphokines and cloned mouse IFN--y on the interaction of R. prowazekii with mouse macrophage-like RAW264.7 cells.
We report that treatment of RAW264.7 cells with lymphokines or cloned IFN-y and infection of the cells with R. prowazekii together result in the killing of a substantial proportion of the RAW264.7 cells. In addition, rickettsial growth is inhibited in the cells that survive the cytotoxic reaction.
Rickettsiae. R. prowazekii E or Breinl was harvested and purified from infected yolk sacs as described previously (24) . Viable rickettsiae were enumerated by the antibody hemolysis method of Walker and Winkler (26) .
Lymphokines. Lymphokines were prepared from cultures of spleen cells from BALB/c mice or C57BL/6J mice according to previously described procedures (22, 24) . BALB (Table 1) . Such cytotoxicity was not observed in uninfected control or uninfected lymphokine-treated RAW264.7 cells, in control cells that were incubated with live or dead R. prowazekii, or in lymphokine-treated cells that were incubated with dead R. prowazekii. At 0 and 4 h after infection, the total number of cells present in measured areas of lymphokine-treated RAW264.7 cell cultures that were infected with viable R. prowazekii was similar to the numbers observed in comparable areas of uninfected lymphokine-treated cultures, uninfected control cultures, and control cultures infected with viable R. prowazekii (Table 2) . Hence, preferential loss of cells from RAW264.7 cell cultures subjected to a given treatment was not observed at these time points. The percentage of cells stained by trypan blue in the lymphokine-treated RAW264.7 cell cultures infected with viable R. prowazekii did not increase between 4 and 24 h after infection (Table 1) . In some experiments, this percentage actually decreased (data not shown). In experiments in which a decrease was observed, many cells had been lost from the substratum of the lymphokine-treated infected cultures by 24 h after infection. The data in Table 2 indicate that extensive cell loss had occurred by 24 h after infection in the lymphokine-treated RAW264.7 cell cultures that were infected with rickettsiae. Extensive loss of RAW264.7 cells was not observed, however, in uninfected lymphokine-treated cultures, uninfected control cultures, or control cultures infected with viable rickettsiae (Table 2) . (Table 2) . Hence, L929 cells were not preferentially lost from any of these cultures.
Either the avirulent strain E or the virulent strain Breinl of R. prowazekii caused cytotoxicity in RAW264.7 cells that were treated with mouse lymphokines (Tables 1 and 3) . Lymphokines were able to induce cytotoxicity when they were added to RAW264.7 cells either before rickettsial infection only or after rickettsial infection only (Table 3) , as well as when they were added both before and after infection ( Table 1) .
Cytotoxicity was also observed in nonirradiated, lymphokine-treated RAW264.7 cells that were infected with R. prowazekii (Table 4 ). In addition, the extent of cytotoxicity was directly proportional to the initial rickettsial infection, and infection of cells with as few as three rickettsiae per cell was sufficient to cause cytotoxicity in lymphokine-treated cells (Table 4) . Effect 0.3, respectively (n = 5 experiments). In three of the five experiments the NR in the lymphokine-treated cultures was less than 60% of the NR in the control cultures.
In the experiments described in Table 5 , the effect of lymphokines on rickettsial growth was examined in cultures of irradiated RAW264.7 cells treated with lymphokines before infection only, after infection only, or both before and after infection. In these experiments, which were complicated by the cytotoxicity described above, only cells which appeared to be intact microscopically were examined for rickettsiae. As expected, in control cultures of RAW264.7 cells, R. prowazekii Breinl grew well: %R increased slightly and RI increased approximately 18-fold during the 48-h incubation period. When RAW264.7 cells were treated with lymphokines, however, %R dropped dramatically during the 48-h incubation period and RI underwent little change. Thus, little or no rickettsial growth occurred in the lymphokinetreated cells that survived the cytotoxic reaction.
Effects and relative activities of various lymphokine preparations. Lymphokines collected from concanavalin A-stimulated cultures of spleen cells obtained from L. monocytogenes-challenged C57BL/6J mice had the same effects (cytotoxicity, inhibition of rickettsial growth, and inhibition of the initial rickettsial infection) as the other lymphokine preparations, but they induced these effects at much lower concentrations (data not shown). In contrast to the lymphokine preparations collected from stimulated cultures, supernatant fluids collected from unstimulated cultures of spleen cells obtained from normal C57BL/6J mice did not inhibit the initial rickettsial infection. Such fluids had cytotoxic activity at a 1/6 dilution but not at higher dilutions and caused only slight (-20%) inhibition of rickettsial growth at a 1/6 dilution, whereas a preparation collected from concanavalin Astimulated cultures of spleen cells obtained from normal C57BL/6J mice had cytotoxic activity and markedly inhibited rickettsial growth at a dilution as high as 1/162. Addition of concanavalin A to an unstimulated culture fluid enhanced neither its cytotoxic activity nor its ability to inhibit rickettsial growth and did not render it able to inhibit the initial rickettsial infection (data not shown). clones. Supernatant fluids collected from five Lyt-1 +,2-murine T lymphocyte clones cultured with concanavalin A or the antigen bovine serum albumin could substitute for crude mouse lymphokines in inducing cytotoxicity in RAW264.7 cells that were also infected with R. prowazekii (Table 6 ). These supernatant fluids also contained IFN and inhibited rickettsial growth in mouse L929 cells (29) .
Comparison of the effects of mouse lymphokines and cloned mouse IFN-,y on the interaction of R. prowazekii Breinl with RAW264.7 cells. We examined the cytotoxic activity, inhibition of the initial rickettsial infection, and inhibition of rickettsial growth in RAW264.7 cells treated before infection with various concentrations of IFN--y as crude mouse lymphokines or cloned mouse IFN-y produced by E. coli (Fig.  1) . The curve for each parameter in mouse lymphokinetreated cells was strikingly similar to the curve for the same parameter in cloned mouse IFN--y-treated cells. Thus, the effects of crude mouse lymphokines on RAW264.7 cells infected with R. prowazekii might be accounted for by the IFN--y that is present in these preparations. Both cytotoxicity and inhibition of rickettsial growth were observed in cells treated with IFN--y at 0.8 IU/0.3 ml as crude lymphokines or cloned IFN--y, and these two parameters reached a maximum in cells treated with IFN--y at approximately 3 IU/0.3 ml. As the IFN--y concentration was increased further, the percent inhibition of rickettsial growth remained at its maximal value (-88%). However, at very high concentrations of IFN--y, cytotoxicity declined somewhat. Marked inhibition of the initial rickettsial infection was observed only at IFN--y concentrations of .12 IU/0.3 ml, and maximal inhibition occurred at an IFN--y concentration of approximately 200 IU/0.3 ml.
Experiments with cloned IFN-y produced by Chinese hamster ovary cells showed that cytotoxicity occurred in RAW264.7 cells treated with cloned IFN--y after rickettsial infection only, as well as in RAW264.7 cells treated with cloned IFN--y before infection only. Cytotoxicity was not observed in cells treated with control medium for this IFN--y and infected with R. prowazekii (data not shown).
DISCUSSION
Most of the antirickettsial activity observed in mouse lymphokine-treated mouse fibroblasts can be accounted for by the IFN--y that is present in the crude lymphokine preparations (22, 23) . Although macrophage-reactive factors other than IFN--y may be present in such preparations, the effects of crude lymphokines that were observed in treated RAW264.7 cells in this study also can be explained in the simplest model by the IFN--y that is present in the lymphokine preparations.
Treatment Inhibition of rickettsial growth also occurred in lymphokine-or IFN--y-treated fibroblastic L929 cells (22, 24) , but cytotoxicity did not. Cytotoxicity was observed in another mouse macrophage-like cell line, J774.1, after lymphokine treatment and infection with R. prowazekii (data not shown); hence, cytotoxicity may be dependent on some function that is present only in macrophage-like cells.
It is also possible that cytotoxicity occurs only in lymphokine-treated macrophages or macrophage-like cells that are infected with this Rickettsia species. In studies conducted by others with R. tsutsugamushi, lymphokine treatment induced rickettsicidal activity in cultures of resident mouse peritoneal macrophages, but killing of lymphokine-treated, infected macrophages was not reported (13, 14) . This may mean that there was no cytotoxicity or that it was not investigated.
Wisseman and Waddell (30) recently showed that supernatant fluids collected from antigen-or mitogen-stimulated (30) . No data were given about the possible cytolytic action of the supernatant fluids on rickettsia-infected macrophages and endothelial cells (30) .
In our experiments, viable rickettsiae were required for cytotoxicity, and either the virulent strain Breinl or the avirulent strain E of R. prowazekii was effective. The effectiveness of both strains is interesting because in untreated cultures of RAW264.7 cells, strain Breinl grows well but strain E does not (21) . Infection of cells with small numbers of rickettsiae was sufficient to cause cytotoxicity in lymphokine-treated cells; however, the percentage of cells killed increased when cells were infected with larger numbers of rickettsiae. The decreased percentages of cells killed in cultures treated with very high concentrations of IFN-y and then infected with R. prowazekii may have been related to the marked inhibition of the initial rickettsial infection that was observed in these cultures.
Many studies have dealt with the inhibitory effect of interferons on the multiplication of cultured cells, and in some reports interferon treatment has been associated with cell death (3, 6, 25) . It may be that infection with R. prowazekii makes RAW264.7 cells more sensitive to the effects of IFN-y. On the other hand, treatment of RAW264.7 cells with IFN--y may make the cells more sensitive to R. prowazekii. A phospholipase A activity is involved in the interaction of R. prowazekii and host cells (28) and may be responsible for the cytotoxicity observed in the present study.
The participation of IFN-y in the activation of macrophages for killing of tumor cells, Toxoplasma gondii, and Leishmania donovani has been demonstrated (10, 12, (15) (16) (17) . Our study shows that IFN-y also alters the interaction of macrophage-like cells with R. prowazekii. Occurrence of cytotoxicity and inhibition of the initial rickettsial infection may reflect IFN--y-induced alterations in the RAW264.7 cell membrane. Treatment of macrophages or macrophage-like cells with lymphokines or IFN-y results in cell surface changes (7, 9, 11, 18, 19, 32) , and treatment of cells with IFN preparations can alter the cytoskeleton and the rate of endocytosis (2, 4, 20, 27) . Such changes might perturb the process by which R. prowazekii enters macrophages.
